AgroSavfe Raises €11M in Series B Funding

agrosavfe_logo-1AgroSavfe NV, a Ghent, Belgium-based agro-biotech company, extended its Series B financing round to €11m.

Sofinnova Partners joined earlier investors Agri Investment Fund, Biovest, Gimv, Globachem, Madeli Participaties, PMV, Qbic and VIB.

The company intends to use the funds to accelerate the development of its novel Agrobodies® as a new generation of biopesticides and to roll out the international registration process.

Established as a spin-off from VIB, and led by Marnix Peferoen, Managing Director, AgroSavfe is advancing Agrobodies, small proteins that are designed and formulated to specifically bind to essential target molecules of crop pests and diseases.



Join the discussion